Analyst Price Targets — BOLT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 20, 2025 10:20 am | — | H.C. Wainwright | $7.00 | $5.75 | TheFly | Bolt Biotherapeutics assumed with a Buy at H.C. Wainwright |
| May 15, 2024 2:13 am | Daina Graybosch | Leerink Partners | $1.00 | $1.32 | StreetInsider | Leerink Partners Downgrades Bolt Biotherapeutics, Inc. (BOLT) to Market Perform 'on Uncertain Platform Outlook' |
Latest News for BOLT
VANCOUVER, BC / ACCESS Newswire / June 12, 2026 / Bolt Metals Corp. ("Bolt" or the "Company") (CSE:BOLT)(OTCQB:PCRCF)(FSE:A3D8AK), is pleased to announce that, further to its press releases dated May 13, 2026, the letter of intent dated October 23, 2025, and the definitive option agreement dated May 12, 2026, as amended (the "Option Agreement"), with Max Iron Brazil Ltd. ("MaxIron"), an entity controlled by Max…
Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $4.31 per share versus the Zacks Consensus Estimate of a loss of $2.85. This compares to a loss of $5.8 per share a year ago.
REDWOOD CITY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported financial results for the first quarter ended March 31, 2026, and provided a business update.
Bolt Biotherapeutics, Inc. (NASDAQ: BOLT - Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 22,704 shares, a growth of 355.3% from the March 31st total of 4,987 shares. Based on an average daily volume of 21,902 shares,
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BOLT.
U.S. House Trading
No House trades found for BOLT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.